Patient Autonomy

Patient autonomy is a core ethical and legal principle in healthcare, asserting that competent adult patients have the right to freely make, accept, refuse, or withdraw from medical treatment decisions based on their own values, after receiving complete and understandable information. Its practical application is "Informed Consent," a concept codified in regulations worldwide and central to data privacy laws like GDPR, especially Article 22 concerning automated individual decision-making. In the context of AI in medicine, this principle is critical. The opacity of some algorithms can undermine a patient's right to be informed. Therefore, as outlined in the WHO's "Ethics and governance of artificial intelligence for health" guidance, ensuring the explainability of AI systems is paramount. This enables clinicians to clearly communicate the AI's reasoning, potential risks, and uncertainties to patients. In risk management, failing to uphold patient autonomy can lead to malpractice litigation, regulatory fines, and severe reputational damage.

In enterprise risk management, especially for medical AI providers or smart hospitals, applying patient autonomy requires a systematic approach. Step 1: Establish an AI Explainability Framework. Following guidance on AI trustworthiness from standards like ISO/IEC TR 24028:2020, enterprises must adopt Explainable AI (XAI) tools to translate complex model decisions into understandable language and visuals for both clinicians and patients. Step 2: Design a Dynamic Consent Management System. This involves moving beyond static paper forms to a digital platform where patients can grant, review, or revoke consent for specific AI applications (e.g., diagnostics, research), aligning with GDPR's requirements for specific and unambiguous consent. Step 3: Implement a Human-in-the-Loop (HITL) Review Mechanism. This ensures that any critical AI-generated medical recommendation is validated by a qualified healthcare professional before being communicated to the patient. A global firm developing AI screening software implemented these steps, achieving a 100% audit pass rate and reducing patient complaints related to diagnostic uncertainty by 20%.

Taiwan enterprises face three primary challenges when implementing patient autonomy in AI healthcare. 1. Regulatory Ambiguity: Taiwan's Medical Care Act, while mandating informed consent, lacks specific guidance on its application to complex AI algorithms (e.g., 'black box' models), creating legal uncertainty. 2. Technology-Ethics Integration Gap: Development teams often prioritize predictive accuracy over model explainability, making it difficult for clinicians to explain an AI's rationale to patients. 3. Insufficient Granularity in Consent: Traditional, broad consent forms fail to provide patients with the fine-grained control they desire over how their sensitive health data is used across different AI models. To overcome these, enterprises should prioritize establishing an internal ethics committee to create AI governance policies based on WHO guidelines (3-month timeline). Next, integrate XAI requirements into the initial design phase of AI development (6-month timeline). Finally, progressively implement a digital consent management platform to enhance patient trust and control (12-month timeline).

Winners Consulting specializes in patient autonomy for Taiwan enterprises, delivering compliant management systems within 90 days. Free consultation: https://winners.com.tw/contact